Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
about
Insulin analogs and cancer: a note of caution.The Cardiovascular Health in Ambulatory Care Research Team performance indicators for the primary prevention of cardiovascular disease: a modified Delphi panel study.Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI)Clinical inertia in patients with T2DM requiring insulin in family practiceCan community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trialClinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?Effectiveness and Tolerability of Second-Line Therapy with Vildagliptin Versus Other Oral Agents in Type 2 Diabetes (EDGE): Post Hoc Sub-Analysis of Bulgarian Data.Breaking Therapeutic Inertia in Type 2 Diabetes: Active Detection of In-Patient Cases Allows Improvement of Metabolic Control at Midterm.Practice Doesn't Always Make Perfect: A Qualitative Study Explaining Why a Trial of an Educational Toolkit Did Not Improve Quality of Care.Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.Management of diabetes mellitus and associated cardiovascular risk factors in Brazil - the Brazilian study on the practice of diabetes careComplications and characteristics of patients referred to a joint diabetes renal clinic in Ireland.Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.Evaluation of glycemic control in patients with type 2 diabetes mellitus in Chinese communities: a cross-sectional study.Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study.Long-term effects of sitagliptin in patients with type 2 diabetes mellitus and hypertension: results from the PROLOGUE study.Reflective and Automatic Processes in Health Care Professional Behaviour: a Dual Process Model Tested Across Multiple Behaviours
P2860
Q33660524-13EBBF8F-A050-4420-BF59-674952F2C1B0Q33874896-1F528E53-7136-4607-A862-1021B8C3DE76Q34351737-D9E0F4C9-CA16-4D1A-85EF-DBDBEE152F8FQ34406309-F009C972-B267-41F4-A3AA-12127B9FBF15Q34596670-870D622D-5452-4514-AC7C-4333E7EFAF7BQ34726295-C0D35E8A-F7B9-4F7A-B7B0-6A913CE3E94AQ34726395-3FEA56BA-2522-4FE7-BD94-D095CEDF4B1AQ35673027-35942622-F029-433E-B4FB-1FD25CBC55C6Q36234576-5BBAF477-39BD-40C2-BBA0-57E123142EECQ36503503-0B488576-7667-4AAA-9A9B-194C3F61DC9DQ37152425-DA330009-482D-4DB4-9842-55A25BC8E45EQ37998946-6F9F731B-4EC6-4D44-8DBE-422D379B60B5Q38473168-03AD34D7-87CD-4AEB-B57D-76F00B8BDAB0Q40180394-F355A5F4-A6B5-49D7-BFA3-E3477C35F5CDQ44566407-D6BEB6FB-0705-4FA1-916D-4324F9A58740Q47977510-4C90E2D6-5847-4E57-A5D3-5D2FAAAABD2BQ49235125-E161AA24-6F7B-42FA-97FB-81298EC5D3AAQ57246231-34688A12-ABD6-4B3C-9F4A-E6C99F26DC67
P2860
Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@ast
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@en
type
label
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@ast
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@en
prefLabel
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@ast
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@en
P2093
P2860
P921
P1476
Treatment gaps in the manageme ...... ith type 2 diabetes in Canada.
@en
P2093
Amparo Casanova
Anatoly Langer
Andrew Steele
David H Fitchett
Diabetes Registry to Improve Vascular Events (DRIVE) Investigators
George Honos
Jean-François Yale
Keith C Dawson
Lawrence A Leiter
P2860
P304
P356
10.1016/S0828-282X(10)70393-7
P577
2010-06-01T00:00:00Z